ArticlebioRxiv : the preprint server for biology2025
RNA sequence design and protein-DNA specificity prediction with NA-MPNN.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
RNA sequence design and protein-DNA binding specificity prediction can both be framed as nucleic acid inverse-folding problems: finding the most likely nucleic acid sequences given a fixed three-dimensional structure of a nucleic acid or nucleic acid-protein complex. While task-specific tools have been developed, no unified deep learning model for nucleic acid inverse folding has been described; a single model would have larger and more diverse datasets available for training and a considerably greater range of applicability. Here we introduce Nucleic Acid MPNN (NA-MPNN), a message-passing neural network that treats proteins, DNA, and RNA within a unified biopolymer graph representation. NA-MPNN outperforms previous methods on RNA sequence design and fixed-dock protein-DNA specificity prediction, and should be broadly useful for
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.